Additive effect of dorzolamide hydrochloride to patients taking travoprost: A retrospective study

Quigley, 2006, The number of people with glaucoma worldwide in 2010 and 2020, Br J Ophthalmol, 90, 253, 10.1136/bjo.2005.081224 Alexander, 2002, Prostaglandin analog treatment of glaucoma and ocular hypertension, Ann Pharmocother, 36, 505 Dubiner, 2004, Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 24 hour period in patients with elevated IOP, Clin Ther, 26, 84, 10.1016/S0149-2918(04)90008-2 van der Valk, 2005, Intraocular pressure-lowering effects of all commonly used glaucoma drugs, Ophthalmology, 112, 1177, 10.1016/j.ophtha.2005.01.042 Becker, 1954, Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox: a preliminary report, Am J Ophthalmol, 37, 13, 10.1016/0002-9394(54)92027-9 Becker, 1955, The effects of the carbonic anhydrase inhibitor acetazolamide on the composition of the aqueous humor, Am J Ophthalmol, 40, 129, 10.1016/0002-9394(55)91845-6 Ingram, 1999, Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes, Am J Ophthalmol, 128, 292, 10.1016/S0002-9394(99)00179-8 Schuman, 2000, Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol, Ophthalmology, 107, 1171, 10.1016/S0161-6420(00)00081-6 O'Conner, 2002, Additive intraocular pressure lowering effect of various medications with latanoprost, Am J Ophthalmol, 133, 836, 10.1016/S0002-9394(02)01418-6 Arici, 1998, Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure, Inter Ophthalmol, 22, 37, 10.1023/A:1006176713983 Maruyama, 2006, Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial, J Glaucoma, 15, 341, 10.1097/01.ijg.0000212240.11219.49 Parrish, 2003, A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study, Am J Opthalmol, 135, 688, 10.1016/S0002-9394(03)00098-9 Martens-Lobenhoffer, 2002, Clinical pharmacokinetics of dorzolamide, Clin Pharmacokinet, 41, 197, 10.2165/00003088-200241030-00004 Lippa, 1992, Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor, Arch Ophthalmol, 110, 495, 10.1001/archopht.1992.01080160073033 Strahlman, 1995, A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol, Arch Ophthalmol, 133, 1009, 10.1001/archopht.1995.01100080061030 Arend, 2000, Altitudinal visual field asymmetry is coupled with altered retinal circulation in patients with normal pressure glaucoma, Br J Ophthalmol, 84, 1008, 10.1136/bjo.84.9.1008 Arend, 2003, Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients, Acta Ophthalmol Scand, 81, 474, 10.1034/j.1600-0420.2003.00122.x